0947 GMT - The health sector's fears about the new Trump administration are overblown, Novartis Chief Executive Vasant Narasimhan says in an interview with Bloomberg at the World Economic Forum in Davos, Switzerland. Trump is likely to be more pro-innovation than the previous Biden administration, he says. However, his rhetoric could undermine trust in the healthcare sector, he adds. The industry will need to balance environmental, social and governance concerns with the Trump administration's position, he says. The CEO noted confidence in Novartis's prospects for the years ahead. Shares trade up 0.31% to CHF89.51. (adam.whittaker@wsj.com)
(END) Dow Jones Newswires
January 21, 2025 04:48 ET (09:48 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.